Quantcast

DePuy ASR Hip Implant Trials to Begin in 2013, Wright & Schulte LLC, Looking Forward to First Trials in New Year

January 8, 2013

First Bellwether Trials in Federal DePuy ASR Hip Implant Litigation Scheduled to Begin This Spring.

Columbus, OH (PRWEB) January 07, 2013

Wright & Schulte LLC, a leading nationwide defective medical device law firm and Ohio personal injury law firm representing plaintiffs in DePuy ASR hip implant lawsuits reports that the first trials in this massive litigation will begin this spring. In an Order issued by the Honorable Judge David A. Katz, who is overseeing the federal DePuy hip implant litigation in U.S. District Court, Northern District of Ohio (MDL 2197), scheduled the litigation´s first trials for May 6, 2013, and July, 8, 2013.

[ohnd.uscourts.gov/assets/Clerks_Office_and_Court_

Records/MDL/2197/CMO-14.pdf]

Wright & Schulte LLC offers free DePuy ASR hip implant lawsuit evaluations to victims of this recalled device. If you or someone you love suffered serious and debilitating complications following implantation of a DePuy ASR hip, please visit yourlegalhelp.com, or call toll-FREE 1-800-399-0795 to learn more about your options for legal recourse.

The DePuy ASR hip implant is a metal-on-metal hip replacement device, a class of hip implants that according to the U.S. Food & Drug Administration (FDA), have been associated with a high rate of complications, including implant loosening, metal poisoning, inflammation, stiffness, impaired mobility, bone and tissue damage, the development of pseudotumors, and debilitating pain. In August 2010, DePuy Orthopaedics, a division of Johnson & Johnson, issued a worldwide recall for the ASR hip replacement devices, after data indicated that more than 12 percent of the devices failed within five years.

[fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/default.htm]

[depuy.com/asr-hip-replacement-recall]

According to court documents, more than 6,000 lawsuits have since been filed against DePuy Orthopaedics and Johnson & Johnson by recipients of the ASR hip implant device in the Northern District of Ohio. The litigation´s first trials will help to test the strength of Plaintiffs´ claims, and provide insight as to how juries might rule in similar cases, according to Wright & Schulte LLC.

According to a report from The New York Times, the FDA allowed metal-on-metal hip implants, including the DePuy ASR hip replacement device, to come to market without human testing. Data now indicates that all-metal hip implants are more likely to fail than devices made from other materials. In May 2011, the FDA ordered five producers of metal-on-metal hips to undertake studies to assess the safety of the devices. Last summer, an FDA advisory panel recommended that patients with metal-on-metal hip implants should be regularly monitored via imaging tests and blood screening to ensure that they are not failing or shedding dangerous levels of metal ions.

[nytimes.com/2012/06/27/health/replacement-hips-focus-of-fda-hearing.html?_r=1]

About Wright & Schulte LLC

Wright & Schulte LLC, a leading personal injury firm, is dedicated to the belief that America´s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged by defective drugs and their side effects, complications from defective medical devices, and unsafe consumer products, and fight tirelessly to ensure that even the world´s most powerful corporations take responsibility for their actions. If you´re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com, or you can reach a DePuy ASR Hip Implant Attorney at 1-800-399-0795.

Contact:

Wright & Schulte LLC

812 East National Road

Vandalia, Ohio 45377

1-800-399-0795

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10295955.htm


Source: prweb



comments powered by Disqus